Novavax
NVAX
#5446
Rank
S$1.93 B
Marketcap
S$11.79
Share price
-3.89%
Change (1 day)
45.63%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of March 2026 : S$1.34 Billion

According to Novavax's latest financial reports the company's total assets are S$1.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$1.51 B-28.78%
2024-12-31S$2.12 B-10.65%
2023-12-31S$2.37 B-21.6%
2022-12-31S$3.02 B-13.08%
2021-12-31S$3.48 B66.4%
2020-12-31S$2.09 B797.83%
2019-12-31S$0.23 B-17.93%
2018-12-31S$0.28 B-29.77%
2017-12-31S$0.40 B-29.1%
2016-12-31S$0.57 B4.51%
2015-12-31S$0.54 B49.73%
2014-12-31S$0.36 B22.42%
2013-12-31S$0.29 B138.02%
2012-12-31S$0.12 B45.16%
2011-12-31S$86.21 M-10.57%
2010-12-31S$96.4 M-19.78%
2009-12-31S$0.12 B9.67%
2008-12-31S$0.10 B-16.58%
2007-12-31S$0.13 B-29.71%
2006-12-31S$0.18 B33.02%
2005-12-31S$0.14 B10.42%
2004-12-31S$0.12 B-11.01%
2003-12-31S$0.14 B43.3%
2002-12-31S$99.77 M-19.69%
2001-12-31S$0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
S$153.04 B 11,262.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$268.06 B 19,802.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$147.21 B 10,829.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$107.50 B 7,881.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$4.10 B 204.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.66 B-50.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.30 B-77.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$10.79 M-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.60 B-55.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.88 B 40.06%๐Ÿ‡บ๐Ÿ‡ธ USA